A majority of women with ovarian cancer are diagnosed with the most advanced stage of the disease. Less than a third of people diagnosed with the condition survive five years. According to a recent study, as the third most frequent type of gynaecological cancer, it caused more than 200,000 recorded deaths worldwide in 2020 alone.
Category: Science
Good news for coffee lovers: Espresso may prevent Alzheimer’s protein clumping
Espresso, whether savoured on its own or combined into a latte, Americano, or even a martini, delivers an ultra-concentrated rush of caffeine to coffee lovers. But it could be doing more than just wake you awake. According to preliminary in vitro laboratory testing, espresso components can suppress tau protein aggregation – a mechanism thought to be linked in the beginning of Alzheimer’s disease.
Diabetes slows healing in the eye, says Indian American led study
For the first time, researchers led by Indian American scientist Dr Ruchi Shah from Cedars-Sinai, have identified two connected disease-associated changes to the cornea that explain how diabetes slows down wound healing in the eye.
Another Alzheimer’s drug, made by Eli Lilly, shows promise to slow disease
Eli Lilly’s Alzheimer’s drug has shown promise to slow down cognitive and functional decline in people who are in early stages of the disease’s progression, according to results of phase 3 trial. This comes on the heels of Eisai and Biogen’s lecanemab, known by the brand name Leqembi, becoming the first to get US Food and Drug Administration’s (FDA) full approval, earlier this month, to slow down disease progression in adult patients with Alzheimer’s disease.
Chandrayaan-3 launch: Led by NASA’s wishes, greetings pour in from across the globe
Greetings and wishes poured in as India launched its third lunar exploration mission Chandrayaan-3 on GSLV Mark 3 (LVM 3) successfully from Andhra Pradesh’s Sriharikota on Friday.
India’s rocket LVM3 puts Chandrayaan-3 spacecraft into orbit
India’s wait for its third moon mission is over as Chandrayaan-3 was launched on GSLV Mark 3 (LVM 3) heavy-lift launch vehicle successfully from the Satish Dhawan Space Centre in Andhra Pradesh’s Sriharikota as per scheduled launch time. Indian Space Research Organization (ISRO) has put together this ambitious project.
WHO classifies non-sugar sweetener Aspartame as possibly carcinogenic to humans, but safe within limits
The World Health Organization (WHO) on Thursday classified non-sugar sweetener aspartame as a possible carcinogen and said it is safe to have it with a daily intake of 40 milligrams per kilogram of a person’s body weight. The International Agency for Research on Cancer (IARC) and the World Health Organization (WHO) and the Food and Agriculture Organization (FAO) Joint Expert Committee on Food Additives (JECFA) released the assessments of the aspartame.
Women scientists are powering India’s moon mission Chandrayaan-3
Even though the Chandrayaan-3 mission is helmed by men, unlike the Chandrayaan-2 mission, a sizable number of women are behind the latest moon mission, said a senior official of Indian Space Research Organization. (ISRO) “There are about 54 female engineers/scientists who worked directly in the Chandrayaan-3 mission. They are associate and deputy project directors and project managers of various systems working at different centres,” a senior official of Indian Space Research Organisation (ISRO) said.
Chandrayaan-3: All set for countdown for India’s third moon mission
The countdown for the launch of Chandrayaan-3, India’s third moon mission, on July 14 is expected to begin soon. The “launch rehearsal” was completed on Monday, July 10. “The ‘Launch Rehearsal’ simulating the entire launch preparation and process lasting 24 hours has been concluded,” said a statement from Indian Space Research Organisation (ISRO).
Indian-origin researchers’ air monitor device can check for Covid, flu & RSV
A team of Indian-origin American researchers has developed a real-time monitor that can detect any of the SARS-CoV-2 virus variants in a room in about five minutes. The inexpensive, proof-of-concept device, developed by combining recent advances in aerosol sampling technology and an ultrasensitive biosensing technique, could also potentially monitor for other respiratory virus aerosols, such as influenza and respiratory syncytial virus (RSV).